Welcome to LookChem.com Sign In|Join Free
  • or
Ethyl 1-benzyl-5-hydroxy-2-isopropyl-1H-indole-3-carboxylate is a synthetic chemical compound with the molecular formula C24H27NO3. It is a derivative of the heterocyclic compound indole, which is widely used in the pharmaceutical industry. ethyl 1-benzyl-5-hydroxy-2-isopropyl-1H-indole-3-carboxylate features a benzyl group, a hydroxyl group, and an isopropyl group attached to the indole core, along with an ethyl ester substituent at the 3-position. Its structural features and properties suggest potential pharmaceutical applications, and it may exhibit biological activity due to its molecular structure. Further research and testing are required to fully understand its potential uses and effects.

951377-40-5

Post Buying Request

951377-40-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

951377-40-5 Usage

Uses

Used in Pharmaceutical Industry:
Ethyl 1-benzyl-5-hydroxy-2-isopropyl-1H-indole-3-carboxylate is used as a pharmaceutical compound for its potential applications in drug development. Its unique molecular structure, which includes a benzyl group, hydroxyl group, isopropyl group, and an ethyl ester substituent, may contribute to its biological activity and therapeutic effects. Further research is needed to explore its specific uses and efficacy in treating various conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 951377-40-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,1,3,7 and 7 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 951377-40:
(8*9)+(7*5)+(6*1)+(5*3)+(4*7)+(3*7)+(2*4)+(1*0)=185
185 % 10 = 5
So 951377-40-5 is a valid CAS Registry Number.

951377-40-5Relevant academic research and scientific papers

Indole Compounds having sphingosine-1-phosphate (S1P) receptor antagonist

-

Page/Page column 12-13, (2010/11/28)

The present invention provides novel compounds having the following general formula I wherein: A, B, X, Y, R1, R2, R3, R4, n, o and p are as defined in the specification. Such compounds are useful for treating a disease or condition selected from the group consisting of glaucoma, dry eye, angiogenesis, cardiovascular conditions or diseases and wound healing.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 951377-40-5